NYSE · CIK 0001108109
CYH COMMUNITY HEALTH SYSTEMS INC
Insider trading from SEC Form 4. Last filing Jun 30, 2026. Close $2.76 on Oct 9, 2026, +11% from the 52-week low and -37% from the high.
COMMUNITY HEALTH SYSTEMS INC (CYH) has 47 SEC Form 4 filings on file from 20 insiders, the latest filed on Jun 30, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
1 open-market trade has been scored at CYH. The newest: Miguel S Benet (President and CMO) sold $84k of stock on Feb 21, 2025, filed Feb 25, 2025, scored 39 (weak).
CYH closed at $2.76 on Oct 9, 2026, 11% above its 52-week low and 37% below its 52-week high.
1 Form 144 notice of planned sales is on file, the latest filed Feb 25, 2025.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at COMMUNITY HEALTH SYSTEMS INC, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 39Weak | Miguel S Benet President and CMO sell | $84k 23,875 shares | -30% | - |
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Feb 25, 2025 | Miguel S. Benet Officer | 23,875 0.02% of outstanding | $84k | Feb 21, 2025 | none |
Transactions
The newest 50 of 211 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | K Ranga Krishnan director | MOption exercise Common Stock | +13,930 | $0.00 | $0 | 170,023 | Jun 30, 2026 |
| Jun 30, 2026 | K Ranga Krishnan director | MOption exercise Stock Units (SU)derivative | -13,931 | $0.00 | $0 | 55,723 | Jun 30, 2026 |
| Jun 1, 2026 | David V. Rice EVP-Clinical Operations & CMO | AGrant or award Common Stock | +30,000 | $0.00 | $0 | 30,000 | Jun 1, 2026 |
| Jun 1, 2026 | David V. Rice EVP-Clinical Operations & CMO | AGrant or award Performance Based Restrictedderivative | +30,000 | $0.00 | $0 | 30,000 | Jun 1, 2026 |
| Jun 1, 2026 | David V. Rice EVP-Clinical Operations & CMO | AGrant or award Stock Options (Right to Buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Jun 1, 2026 |
| Apr 22, 2026 | K Ranga Krishnan director | MOption exercise Common Stock | +46,950 | $0.00 | $0 | 156,093 | Apr 22, 2026 |
| Apr 22, 2026 | K Ranga Krishnan director | MOption exercise Restricted Stock Unitsderivative | -46,950 | $0.00 | $0 | 228,321 | Apr 22, 2026 |
| Mar 1, 2026 | John A Clerico director | MOption exercise Common Stock | +9,756 | $0.00 | $0 | 327,924 | Mar 3, 2026 |
| Mar 1, 2026 | Elizabeth T Hirsch director | MOption exercise Common Stock | +9,756 | $0.00 | $0 | 121,220 | Mar 3, 2026 |
| Mar 1, 2026 | Hubert James Williams director | MOption exercise Common Stock | +9,756 | $0.00 | $0 | 171,024 | Mar 3, 2026 |
| Mar 1, 2026 | Kevin A Stockton EVP, Operations & Development | MOption exercise Common Stock | +50,000 | $0.00 | $0 | 213,863 | Mar 3, 2026 |
| Mar 1, 2026 | Susan W Brooks director | MOption exercise Common Stock | +9,756 | $0.00 | $0 | 67,856 | Mar 3, 2026 |
| Mar 1, 2026 | Jason K Johnson EVP & CFO | MOption exercise Common Stock | +30,000 | $0.00 | $0 | 202,049 | Mar 3, 2026 |
| Mar 1, 2026 | Michael Dinkins director | MOption exercise Common Stock | +9,756 | $0.00 | $0 | 204,976 | Mar 3, 2026 |
| Mar 2, 2026 | Wayne T Smith director | GGift Common Stock | -19,400 | $0.00 | $0 | 5,217,579 | Mar 3, 2026 |
| Mar 1, 2026 | Justin D Pitt Pres,Chief Legal&Admin Officer | MOption exercise Common Stock | +30,000 | $0.00 | $0 | 272,672 | Mar 3, 2026 |
| Mar 1, 2026 | James S. Ely III director | MOption exercise Common Stock | +9,756 | $0.00 | $0 | 372,037 | Mar 3, 2026 |
| Mar 1, 2026 | John A Fry director | MOption exercise Common Stock | +9,756 | $0.00 | $0 | 228,127 | Mar 3, 2026 |
| Mar 1, 2026 | Phillip A. Posey SVP & CAO | AGrant or award Common Stock | +25,000 | $0.00 | $0 | 52,924 | Mar 3, 2026 |
| Mar 1, 2026 | Kevin J Hammons CEO | MOption exercise Common Stock | +156,240 | $0.00 | $0 | 792,441 | Mar 3, 2026 |
| Mar 1, 2026 | Fawn D Lopez director | AGrant or award Restricted Stock Unitsderivative | +52,023 | $0.00 | $0 | 52,023 | Mar 3, 2026 |
| Mar 1, 2026 | K Ranga Krishnan director | AGrant or award Restricted Stock Unitsderivative | +52,023 | $0.00 | $0 | 275,271 | Mar 3, 2026 |
| Mar 1, 2026 | John A Fry director | MOption exercise Common Stock | +20,906 | $0.00 | $0 | 249,033 | Mar 3, 2026 |
| Mar 1, 2026 | Jason K Johnson EVP & CFO | AGrant or award Common Stock | +90,000 | $0.00 | $0 | 292,049 | Mar 3, 2026 |
| Mar 1, 2026 | Ronald L Burgess Jr director | AGrant or award Restricted Stock Unitsderivative | +52,023 | $0.00 | $0 | 174,542 | Mar 3, 2026 |
| Mar 1, 2026 | Hubert James Williams director | MOption exercise Common Stock | +20,906 | $0.00 | $0 | 191,930 | Mar 3, 2026 |
| Mar 1, 2026 | Kevin A Stockton EVP, Operations & Development | AGrant or award Common Stock | +30,000 | $0.00 | $0 | 243,863 | Mar 3, 2026 |
| Mar 1, 2026 | Phillip A. Posey SVP & CAO | FTax withholding Common Stock | -1,188 | $3.46 | $4,110 | 51,736 | Mar 3, 2026 |
| Mar 1, 2026 | Elizabeth T Hirsch director | MOption exercise Common Stock | +20,906 | $0.00 | $0 | 142,126 | Mar 3, 2026 |
| Mar 1, 2026 | William Norris Jennings director | AGrant or award Restricted Stock Unitsderivative | +52,023 | $0.00 | $0 | 275,271 | Mar 3, 2026 |
| Mar 1, 2026 | Susan W Brooks director | MOption exercise Common Stock | +20,906 | $0.00 | $0 | 88,762 | Mar 3, 2026 |
| Mar 1, 2026 | Justin D Pitt Pres,Chief Legal&Admin Officer | AGrant or award Common Stock | +40,000 | $0.00 | $0 | 312,672 | Mar 3, 2026 |
| Mar 1, 2026 | Kevin J Hammons CEO | AGrant or award Common Stock | +200,000 | $0.00 | $0 | 992,441 | Mar 3, 2026 |
| Mar 1, 2026 | John A Clerico director | MOption exercise Common Stock | +20,906 | $0.00 | $0 | 348,830 | Mar 3, 2026 |
| Mar 1, 2026 | Michael Dinkins director | MOption exercise Common Stock | +20,906 | $0.00 | $0 | 225,882 | Mar 3, 2026 |
| Mar 1, 2026 | James S. Ely III director | MOption exercise Common Stock | +20,906 | $0.00 | $0 | 392,943 | Mar 3, 2026 |
| Mar 1, 2026 | Hubert James Williams director | MOption exercise Common Stock | +19,933 | $0.00 | $0 | 211,863 | Mar 3, 2026 |
| Mar 1, 2026 | John A Fry director | MOption exercise Common Stock | +19,933 | $0.00 | $0 | 268,966 | Mar 3, 2026 |
| Mar 1, 2026 | John A Clerico director | MOption exercise Common Stock | +19,933 | $0.00 | $0 | 368,763 | Mar 3, 2026 |
| Mar 1, 2026 | Jason K Johnson EVP & CFO | FTax withholding Common Stock | -23,610 | $3.46 | $82k | 268,439 | Mar 3, 2026 |
| Mar 1, 2026 | Susan W Brooks director | MOption exercise Common Stock | +19,933 | $0.00 | $0 | 108,695 | Mar 3, 2026 |
| Mar 1, 2026 | Joseph Arthur Hastings director | AGrant or award Restricted Stock Unitsderivative | +52,023 | $0.00 | $0 | 221,492 | Mar 3, 2026 |
| Mar 1, 2026 | Elizabeth T Hirsch director | MOption exercise Common Stock | +19,933 | $0.00 | $0 | 162,059 | Mar 3, 2026 |
| Mar 1, 2026 | Phillip A. Posey SVP & CAO | AGrant or award Performance Based Restrictedderivative | +25,000 | $0.00 | $0 | 25,000 | Mar 3, 2026 |
| Mar 1, 2026 | Justin D Pitt Pres,Chief Legal&Admin Officer | FTax withholding Common Stock | -24,922 | $3.46 | $86k | 287,750 | Mar 3, 2026 |
| Mar 1, 2026 | Kevin A Stockton EVP, Operations & Development | FTax withholding Common Stock | -35,573 | $3.46 | $123k | 208,290 | Mar 3, 2026 |
| Mar 1, 2026 | Kevin J Hammons CEO | FTax withholding Common Stock | -96,896 | $3.46 | $335k | 895,545 | Mar 3, 2026 |
| Mar 1, 2026 | Michael Dinkins director | MOption exercise Restricted Stock Unitsderivative | -9,756 | $0.00 | $0 | 0 | Mar 3, 2026 |
| Mar 1, 2026 | James S. Ely III director | MOption exercise Common Stock | +19,933 | $0.00 | $0 | 412,876 | Mar 3, 2026 |
| Mar 1, 2026 | John A Fry director | MOption exercise Restricted Stock Unitsderivative | -9,756 | $0.00 | $0 | 0 | Mar 3, 2026 |
Insiders
Everyone who has filed a Form 4 here.
- Miguel S BenetPresident and CMO
- Ronald L Burgess Jrdirector
- Susan W Brooksdirector
- John A Clericodirector
- Michael Dinkinsdirector
- James S. Ely IIIdirector
- John A Frydirector
- Kevin J HammonsCEO
- Joseph Arthur Hastingsdirector
- Elizabeth T Hirschdirector
- William Norris Jenningsdirector
- Jason K JohnsonEVP & CFO
- K Ranga Krishnandirector
- Fawn D Lopezdirector
- Justin D PittPres,Chief Legal&Admin Officer
- Phillip A. PoseySVP & CAO
- David V. RiceEVP-Clinical Operations & CMO
- Wayne T Smithdirector
- Kevin A StocktonEVP, Operations & Development
- Hubert James Williamsdirector
Questions about CYH
Answered from the filings on this page, as of the latest one.
Are insiders buying CYH?
No. In the last 90 days no insider at COMMUNITY HEALTH SYSTEMS INC bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade CYH on the open market?
Miguel S Benet (President and CMO) sold $84k of CYH on Feb 21, 2025 and filed the Form 4 on Feb 25, 2025. InsiderTell scored 39 (weak).
How many insiders file Form 4 at COMMUNITY HEALTH SYSTEMS INC?
20 people have filed a Form 4 at COMMUNITY HEALTH SYSTEMS INC, among them Miguel S Benet (President and CMO), Ronald L Burgess Jr (director), Susan W Brooks (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.